Mostrar el registro sencillo del ítem
dc.contributor.author | Álvarez González, Daniel | |
dc.contributor.author | Gutiérrez Tobal, Gonzalo César | |
dc.contributor.author | Campo Matias, Félix del | |
dc.contributor.author | Hornero Sánchez, Roberto | |
dc.date.accessioned | 2016-12-14T07:43:22Z | |
dc.date.available | 2016-12-14T07:43:22Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | Expert Opinion on Therapeutic Patents, 2015, vol. 25:9,p. 971-989 | es |
dc.identifier.issn | 1354-3776 | es |
dc.identifier.uri | http://uvadoc.uva.es/handle/10324/21683 | |
dc.description | Producción Científica | es |
dc.description.abstract | Introduction. Obstructive sleep apnea-hypopnea syndrome (OSAHS) is a major health problem with significant negative effects on the health and quality of life. Continuous positive airway pressure (CPAP) is currently the primary treatment option and it is considered the most effective therapy for OSAHS. Nevertheless, comfort issues due to improper fit to patient’s changing needs and breathing gas leakage limit the patient’s adherence to treatment. Areas covered. The present patent review describes recent innovations in the treatment of OSAHS related to optimization of the positive pressure delivered to the patient, methods and systems for continuous self-adjusting pressure during inspiration and expiration phases, and techniques for electrical stimulation of nerves and muscles responsible for the airway patency. Expert opinion. In the last years, CPAP-related inventions have mainly focused on obtaining an optimal self-adjusting pressure according to patient’s needs. Despite intensive research carried out, treatment compliance is still a major issue. Hypoglossal electrical nerve stimulation could be an effective secondary treatment option when CPAP primary therapy fails. Several patents have been granted focused on selective stimulation techniques and parameter optimization of the stimulating pulse waveform. Nevertheless, there remain important issues to address, like effectiveness and adverse events due to improper stimulation. | es |
dc.format.mimetype | application/pdf | es |
dc.language.iso | eng | es |
dc.publisher | Taylor & Francis | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Airflow limitation | es |
dc.title | Positive airway pressure and electrical stimulation methods for obstructive sleep apnea treatment: a patent review (2005-2014) | es |
dc.type | info:eu-repo/semantics/article | es |
dc.identifier.doi | 10.1517/13543776.2015.1054094 | es |
dc.peerreviewed | SI | es |
dc.description.project | Ministerio de Economía y Competitividad (TEC2011-22987) | es |
dc.description.project | Junta de Castilla y León (VA059U13) | es |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
La licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International